Brett P. Monia
Chief Executive Officer at Ionis Pharmaceuticals Inc.
Sits on 2 boards. Last updated September 28, 2026
Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: Ionis Pharmaceuticals Inc., 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Cognition Therapeutics Inc. June 7, 202496.9%
-
Ionis Pharmaceuticals Inc. June 6, 202497.7%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 31, 2026 | Ionis Pharmaceuticals Inc. | Other | +98 | $51.31 | $5,028 |
| Jun 26, 2026 | Ionis Pharmaceuticals Inc. | Option exercise | +50,000 | $56.78 | $2,839,000 |
| Jun 26, 2026 | Ionis Pharmaceuticals Inc. | Open-market sale | −50,000 | $80.59 | $4,029,500 |
| Jun 25, 2026 | Ionis Pharmaceuticals Inc. | Option exercise | +21,072 | $32.60 | $686,947 |
| Jun 25, 2026 | Ionis Pharmaceuticals Inc. | Open-market sale | −21,072 | $78.49 | $1,653,941 |
| Jun 24, 2026 | Ionis Pharmaceuticals Inc. | Option exercise | +14,565 | $32.60 | $474,819 |
| Jun 24, 2026 | Ionis Pharmaceuticals Inc. | Open-market sale | −14,565 | $78.41 | $1,142,042 |
| Jun 17, 2026 | Cognition Therapeutics Inc. | Grant or award | +25,000 | — | — |
| May 14, 2026 | Ionis Pharmaceuticals Inc. | Option exercise | +3,220 | $32.60 | $104,972 |
| May 14, 2026 | Ionis Pharmaceuticals Inc. | Open-market sale | −3,220 | $78.68 | $253,350 |
| May 13, 2026 | Ionis Pharmaceuticals Inc. | Option exercise | +1,316 | $32.60 | $42,902 |
| May 13, 2026 | Ionis Pharmaceuticals Inc. | Open-market sale | −1,316 | $78.01 | $102,661 |
| Mar 10, 2026 | Ionis Pharmaceuticals Inc. | Option exercise | +34,103 | $60.89 | $2,076,532 |
| Mar 10, 2026 | Ionis Pharmaceuticals Inc. | Open-market sale | −16,512 | $75.47 | $1,246,161 |
| Mar 10, 2026 | Ionis Pharmaceuticals Inc. | Open-market sale | −17,591 | $76.34 | $1,342,897 |
Questions about Brett P. Monia
What boards is Brett P. Monia on?
Brett P. Monia sits on the boards of Cognition Therapeutics Inc. and Ionis Pharmaceuticals Inc.
What company is Brett P. Monia the CEO of?
Brett P. Monia is Chief Executive Officer of Ionis Pharmaceuticals Inc.
How long has Brett P. Monia served on boards?
Our records show at least 7 years of board service across 2 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.